Commentary by Helen Kourlas PharmD, Pharmacology Section Editor
On October 16th the FDA announced the approval of raltegravir (Isentress®) for the treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents. The …
Commentary by Kathy Lee, Pharm.D. Pharmacy Practice Resident
Commentary by Helen Kourlas, PharmD
–Commentary by Susan Morey, PharmD. Pharmacy Practice Resident